Schedule 13G ownership disclosure
LONGBOARD PHARMACEUTICALS IN
Security class unavailable · CUSIP: 54300N103
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,024,616
- Percent of class
- 14.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-22-002257
- Form type
- SC 13G
- Filer
- Longboard Pharmaceuticals, Inc.
- CIK
- CIK 1832168
- Filed
- Feb 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership